Dianlong Jia

Fusion to an albumin-binding domain with a high affinity for albumin extends the circulatory half-life and enhances the in vivo antitumor effects of human TRAIL

Rui Li, Hao Yang, Dianlong Jia et al. · Journal of Controlled Release · 2016 · 79 citations

Medicine, Cell Trafficking, Cell-matrix Interaction +10

Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy

Haijun Wang, Dianlong Jia, Dandan Yuan et al. · Journal of Nanobiotechnology · 2021 · 45 citations · Full text

Development of Clioquinol Platinum(IV) Conjugates as Autophagy-Targeted Antimetastatic Agents

Ming Zhang, Linming Li, Suying Li et al. · Journal of Medicinal Chemistry · 2023 · 41 citations

Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects

Hao Yang, Yanru Feng, Huawei Cai et al. · Theranostics · 2018 · 26 citations · Full text

Modulation of pericytes by a fusion protein comprising of a PDGFRβ-antagonistic affibody and TNFα induces tumor vessel normalization and improves chemotherapy

Qing Fan, Ze Tao, Hao Yang et al. · Journal of Controlled Release · 2019 · 26 citations

Tumor Biology, Angiogenesis, Fusion Protein Comprising +11